Nocturia is more bothersome than daytime LUTS: Results from an Observational, Real-life Practice Database including 8659 European and American LUTS patients

International Journal of Clinical Practice
Karel EveraertTove Holm-Larsen

Abstract

Lower urinary tract symptoms (LUTS) encompass several diagnoses, including overactive bladder (OAB) and benign prostatic hyperplasia (BPH). Nocturia is a standalone symptom, but also included in OAB and BPH. Current discussion addresses whether the overlap of the diagnoses is too broad, leading to misdiagnosis. This study explored the differences in level, causes and consequences for patients with a diagnosis of daytime LUTS compared with a diagnosis of nocturia, and discussed whether people are being treated for the symptoms that truly bother them the most. Data were drawn from a survey of physicians and patients in France, Germany, Spain, UK and USA. Physicians filled out patient record forms (PRFs) for patients with LUTS diagnosis. The patients completed the patient self-completion form (PSC). Three PRO questionnaires were included; the OAB-q SF, NI-Diary and WPAI. Patients were grouped based on the diagnoses assigned to them by their physicians in a real-life setting. Eight thousand seven hundred and thirty eight patients had a LUTS diagnosis and 5335 completed a PSC. Patients diagnosed with night-time symptoms were significantly more bothered by their LUTS than only daytime LUTS patients (all questionnaires P < .0001). Pat...Continue Reading

References

Feb 16, 2000·BJU International·P van Kerrebroeck, J Weiss
Feb 22, 2002·Neurourology and Urodynamics·Paul AbramsUNKNOWN Standardisation Sub-committee of the International Continence Society
Dec 21, 2002·Urology·Alan J Wein, Eric S Rovner
Mar 31, 2004·BJU International·C W McGrotherUNKNOWN MRC Incontinence Study Team
Nov 5, 2011·International Urogynecology Journal·Daniele FurtadoSergio Tufik
Jul 12, 2013·Postgraduate Medicine·Raymond C RosenAlan J Wein
May 20, 2014·Neurourology and Urodynamics·Marcus J Drake
Sep 23, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Tove Holm-LarsenJens Peter Nørgaard
Oct 18, 2014·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Donald L BliwiseJens Peter Nørgaard
Dec 17, 2014·Journal of Psychosomatic Research·Desiree VrijensCarsten Leue
Mar 19, 2015·Neurourology and Urodynamics·Karin S CoyneChris C Sexton
Mar 10, 2016·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Yohannes W EndeshawUNKNOWN Health ABC Study

❮ Previous
Next ❯

Citations

Dec 21, 2019·International Urology and Nephrology·Pinar SoysalLee Smith
Jul 3, 2020·RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin·Attila KovácsUNKNOWN In Zusammenarbeit mit der DeGIR-Lenkungsgruppe Wissenschaft und dem DeGIR-Vorstand
Nov 7, 2019·Female Pelvic Medicine & Reconstructive Surgery·Michael DaughertyTimothy Byler
Jul 17, 2019·Urology·Donald L BliwisePeter K Sand
Nov 19, 2020·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Valerie WilliamsFredrik L Andersson
Dec 10, 2020·Global Advances in Health and Medicine : Improving Healthcare Outcomes Worldwide·Steven P HirshAndrew G Swick
Mar 20, 2021·Menopause : the Journal of the North American Menopause Society·Kim PauwaertKarel Everaert
May 12, 2021·Neurourology and Urodynamics·Connelly D MillerJeffrey P Weiss

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.